Accès ouvert
2026
review
OpenAlex
Noora Jatan, Sami Talo, Aida J. Azar, Thomas Edward Adrian et autres
BACKGROUND: Aromatase inhibitors anastrozole and letrozole (non-steroidal, reversible), and exemestane (steroidal, irreversible) are approved standard therapies (Food and Drug Administration) for hormone receptor-positive breast cancer. Their use is limited by Aromatase Inhibitor-induced Musculoskeletal Signs and Symptoms (AIMSS). METHODS: Articles on AIMSS mechanisms …
ae
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Hardik Ghelani, Hala Altaher, Hadil Sarsour, Marah Tabbal et autres
Background: Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide. The search for effective, new antineoplastic drugs with fewer side effects for the treatment of CRC continues, with marine-derived compounds emerging as promising candidates. Objectives: This study investigates the …
ae
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Hardik Ghelani, Kerat Hanspal, Lana Talo, Sami Talo et autres
Introduction Frondanol, a non-polar lipid extract derived from the edible sea cucumber Cucumaria frondosa, has shown promising anti-inflammatory properties. Methods This study investigated its molecular mechanisms in modulating inflammation using lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages. Results Frondanol was found to be …
ae, us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Rakesh Kumar, Sarika Saini, M.J. Vrancken Peeter, K. Amulya et autres
Accès ouvert
2023
article
OpenAlex
Md Khursheed, Hardik Ghelani, Reem Kais Jan, Thomas Edward Adrian
Inflammation is a defense mechanism of the body in response to harmful stimuli such as pathogens, damaged cells, toxic compounds or radiation. However, chronic inflammation plays an important role in the pathogenesis of a variety of diseases. Multiple anti-inflammatory drugs are currently …
ae
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Vishnu Raj, Balaji Venkataraman, Shreesh Kumar Ojha, Saeeda Almarzooqi et autres
Inflammation of the GI tract leads to compromised epithelial barrier integrity, which increases intestine permeability. A compromised intestinal barrier is a critical event that leads to microbe entry and promotes inflammatory responses. Inflammatory bowel diseases that comprise Crohn's disease (CD) and ulcerative …
ae, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Balaji Venkataraman, Saeeda Almarzooqi, Vishnu Raj, Bhoomendra A. Bhongade et autres
Inflammatory bowel disease, comprising Crohn's disease (CD) and ulcerative colitis (UC), is often debilitating. The disease etiology is multifactorial, involving genetic susceptibility, microbial dysregulation, abnormal immune activation, and environmental factors. Currently, available drug therapies are associated with adverse effects when used long-term. …
ae, in, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Marah Tabbal, Mahmood Yaseen Hachim, Reem Kais Jan, Thomas Edward Adrian
Introduction: Although the risk of breast cancer increases with advancing age, some regions have larger number of young breast cancer patients (≤45 years-old), such as the Middle East, Eastern Asia, and North Africa, with more aggressive and poorly differentiated tumors. We aimed …
ae
(code pays fourni par la source)
Accès ouvert
2023
supplementary-materials
OpenAlex
Thomas Edward Adrian, Mads Hornum, Knop F.K, Karl Bang Christensen et autres
Background. Non-alcoholic fatty liver disease (NAFLD), and particularly liver fibrosis, has been suggested as a risk factor of chronic kidney disease (CKD). Given that NAFLD affects every fourth person globally, better insight is needed. Our aim was to investigate the association between …
Accès ouvert
2022
article
OpenAlex
Saeeda Almarzooqi, Balaji Venkataraman, Vishnu Raj, Sultan Ali Abdulla Alkuwaiti et autres
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders that include Crohn's disease (CD) and ulcerative colitis (UC). The incidence of IBD is rising globally. However, the etiology of IBD is complex and governed by multiple factors. The current clinical treatment for IBD …
ae, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hardik Ghelani, Thomas Edward Adrian, Samuel B. Ho, Jamil Akhras et autres
Introduction: has been reported to possess potent anti-inflammatory effects, likely mediated by the inhibition of 5-lipoxygenase and 12-lipoxygenase pathways, whilst showing no signs of toxicity. The potent anti-inflammatory effects of Frondanol in a mouse model of IBD provide encouragement for investigating its …
ae
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hardik Ghelani, Md Khursheed, Thomas Edward Adrian, Reem Kais Jan
Chronic inflammation can extensively burden a healthcare system. Several synthetic anti-inflammatory drugs are currently available in clinical practice, but each has its own side effect profile. The planet is gifted with vast and diverse oceans, which provide a treasure of bioactive compounds, …
ae
(code pays fourni par la source)